UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of suggestion on the human experimental model of cold hyperalgesia after topical application of high‐concentration menthol [40%]

European journal of pain, 2018-09, Vol.22 (8), p.1517-1527

2018

Volltextzugriff (PDF)

Multiple Dose Pharmacokinetics of Tapentadol Oral Solution for the Treatment of Moderate to Severe Acute Pain in Children Aged 2 to 7 Years

Journal of pain research, 2022-10, Vol.15, p.3103-3114

2022

Volltextzugriff (PDF)

Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir

Clinical pharmacology and therapeutics, 2006-08, Vol.80 (2), p.126-135

2006

Volltextzugriff (PDF)

Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics

Clinical pharmacology and therapeutics, 2005-07, Vol.78 (1), p.25-33

2005

Volltextzugriff (PDF)

Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin–clarithromycin interaction

British journal of clinical pharmacology, 2003-07, Vol.56 (1), p.32-38

2003

Volltextzugriff (PDF)

A thorough QT/QTc study of multiple doses of tapentadol immediate release in healthy subjects

International journal of clinical pharmacology and therapeutics, 2010-10, Vol.48 (10), p.678-687

2010

Volltextzugriff (PDF)

Effects of a divided high loading dose of caffeine on circulatory variables in preterm infants

Archives of disease in childhood. Fetal and neonatal edition, 2006-01, Vol.91 (1), p.F61-F64

2006

Volltextzugriff (PDF)

Influence on study outcomes of an inpatient study by the behavior of the study staff (PINgPOng): study protocol for a randomized clinical trial

Trials, 2022-06, Vol.23 (1), p.488-488, Article 488

2022

Volltextzugriff (PDF)

Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma

Pediatric Blood & Cancer, 2007-08, Vol.49 (2), p.203-207

2007

Volltextzugriff (PDF)

ADME transcriptome in Hispanic versus White donor livers: Evidence of a globally enhanced NR1I3 (CAR, constitutive androstane receptor) gene signature in Hispanics

Xenobiotica, 2006-10, Vol.36 (10-11), p.989-1012

2006

Volltextzugriff (PDF)

Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trials

European Journal of Clinical Pharmacology, 2017-04, Vol.73 (4), p.409-416

2017

Volltextzugriff (PDF)

Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations

International journal of clinical pharmacology and therapeutics, 2013-04, Vol.51 (4), p.338-348

2013

Volltextzugriff (PDF)

Reduction in non-glomerular renal clearance of the caffeine metabolite 1-methylxanthine by probenecid

International journal of clinical pharmacology and therapeutics, 2007-08, Vol.45 (8), p.431-437

2007

Volltextzugriff (PDF)

Population pharmacokinetic/pharmacodynamic modelling of the effects of axomadol and its O‐demethyl metabolite on pupil diameter and nociception in healthy subjects

British journal of clinical pharmacology, 2016-07, Vol.82 (1), p.92-107

2016

Volltextzugriff (PDF)

Effects of Acetaminophen, Naproxen, and Acetylsalicylic Acid on Tapentadol Pharmacokinetics: Results of Two Randomized, Open-Label, Crossover, Drug-Drug Interaction Studies

Pharmacotherapy, 2010-01, Vol.30 (1), p.25-34

2010

Volltextzugriff (PDF)

Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria

European journal of clinical pharmacology, 2004-12, Vol.60 (10), p.709-715

2004

Volltextzugriff (PDF)

Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]

Malaria journal, 2005-09, Vol.4 (1), p.45-45, Article 45

2005

Volltextzugriff (PDF)

Pharmacokinetics and Tolerability of Tapentadol Immediate Release (IR) in Subjects With Hepatic or Renal Impairment: 397

The American journal of gastroenterology, 2009-10, Vol.104, p.S149

2009

Volltextzugriff (PDF)

Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?

European journal of clinical pharmacology, 2005, Vol.60 (11), p.807-811

2005

Volltextzugriff (PDF)

Inhibition of the human organic anion transporter 1 by the caffeine metabolite 1-methylxanthine

Biochemical and biophysical research communications, 2004-07, Vol.320 (1), p.90-94

2004

Volltextzugriff (PDF)

Decolonization of methicillin-resistant Staphylococcus aureus by disinfection of the skin

The American journal of medicine, 2000-06, Vol.108 (8), p.685-686

2000

Volltextzugriff (PDF)

Familial Mediterranean fever. New aspects with respect to molecular genetics and pathogenesis revealed in three case reports

Medizinische Klinik (München. 1983), 1999-12, Vol.94 (12), p.685-689

1999

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(18)

Publikationsform

Artikel
(22)

Sprache

Englisch
(21)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(18)
Life Sciences & Biomedicine
(18)
Science & Technology
(18)
Male
(12)
Adult
(11)
Pharmacology & Pharmacy
(11)
Biological And Medical Sciences
(7)
Cross-Over Studies
(7)
Female
(7)
Medical Sciences
(7)
Pharmacology. Drug Treatments
(7)
Area Under Curve
(6)
Administration, Oral
(5)
Double-Blind Method
(5)
Pharmacokinetics
(5)
Dose-Response Relationship, Drug
(4)
Middle Aged
(4)
Aged
(3)
Analgesics
(3)
Aryl Hydrocarbon Hydroxylases - Genetics
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of suggestion on the human experimental model of cold hyperalgesia after topical application of high‐concentration menthol [40%]

Multiple Dose Pharmacokinetics of Tapentadol Oral Solution for the Treatment of Moderate to Severe Acute Pain in Children Aged 2 to 7 Years

Potent cytochrome P450 2C19 genotype-related interaction between voriconazole and the cytochrome P450 3A4 inhibitor ritonavir

Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics

Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin–clarithromycin interaction

A thorough QT/QTc study of multiple doses of tapentadol immediate release in healthy subjects

Effects of a divided high loading dose of caffeine on circulatory variables in preterm infants

Influence on study outcomes of an inpatient study by the behavior of the study staff (PINgPOng): study protocol for a randomized clinical trial

Successful treatment with voriconazole of Aspergillus brain abscess in a boy with medulloblastoma

ADME transcriptome in Hispanic versus White donor livers: Evidence of a globally enhanced NR1I3 (CAR, constitutive androstane receptor) gene signature in Hispanics

Who is a ‘healthy subject’?—consensus results on pivotal eligibility criteria for clinical trials

Comparative pharmacokinetics and bioavailability of tapentadol following oral administration of immediate- and prolonged-release formulations

Reduction in non-glomerular renal clearance of the caffeine metabolite 1-methylxanthine by probenecid

Population pharmacokinetic/pharmacodynamic modelling of the effects of axomadol and its O‐demethyl metabolite on pupil diameter and nociception in healthy subjects

Effects of Acetaminophen, Naproxen, and Acetylsalicylic Acid on Tapentadol Pharmacokinetics: Results of Two Randomized, Open-Label, Crossover, Drug-Drug Interaction Studies

Pharmacokinetic interaction of chloroquine and methylene blue combination against malaria

Safety of the methylene blue plus chloroquine combination in the treatment of uncomplicated falciparum malaria in young children of Burkina Faso [ISRCTN27290841]

Pharmacokinetics and Tolerability of Tapentadol Immediate Release (IR) in Subjects With Hepatic or Renal Impairment: 397

Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management?

Inhibition of the human organic anion transporter 1 by the caffeine metabolite 1-methylxanthine

Decolonization of methicillin-resistant Staphylococcus aureus by disinfection of the skin

Familial Mediterranean fever. New aspects with respect to molecular genetics and pathogenesis revealed in three case reports

Suchergebnisse filtern